RE: RE: RE: RE: RE: RE: RE: RE: RE: Albiglutide Stockman,
What I think is that they would pay a licence, or an exclusity right on a use of one specific ligand for a diabet drug, like we think that Celgene bought the rightson a specific application, i.e., a cancer drug.
There's a patent on PLI technology, and they wouldn't be able to produce it and use it without being sued.
If I push a little this reflexion, and I'm not a lawyer, I think that (If I was the client) I would have a clause in the licence agreement or supply agreement to be entitle to have the full receipe and use it if for some reason PLI couldn't deliver the orders. They are not making toasters, and just can't change the way to manufacture a drug without going back to regulatory approval, so I can imagine it would be only in this circonstance that a client should be allowed to manufacture himself any ligands.